Publicaciones en colaboración con investigadores/as de Universidad de Navarra (27)

2022

  1. Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APPswe Alzheimer’s Disease Mouse Model

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

2021

  1. Corticosteroid-binding-globulin (CBG)deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampus

    PLoS ONE, Vol. 16, Núm. 2 February

2018

  1. Adrenomedullin, a Novel Target for Neurodegenerative Diseases

    Molecular Neurobiology, Vol. 55, Núm. 12, pp. 8799-8814

  2. Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer’s Disease

    Molecular Neurobiology, Vol. 55, Núm. 6, pp. 5177-5183

  3. Maternal imprinting on cognition markers of wild type and transgenic Alzheimer's disease model mice

    Scientific Reports, Vol. 8, Núm. 1

  4. Reduced Adrenomedullin Parallels Microtubule Dismantlement in Frontotemporal Lobar Degeneration

    Molecular Neurobiology, Vol. 55, Núm. 12, pp. 9328-9333

2017

  1. Adrenomedullin contributes to age-related memory loss in mice and is elevated in aging human brains

    Frontiers in Molecular Neuroscience, Vol. 10

  2. Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1863, Núm. 4, pp. 991-1001

2016

  1. Down-regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease

    Hippocampus, Vol. 26, Núm. 10, pp. 1303-1312

2015

  1. Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer's disease

    Aging Cell, Vol. 14, Núm. 1, pp. 122-129

  2. Decreased levels of guanosine 3', 5'-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease

    Neuropathology and Applied Neurobiology, Vol. 41, Núm. 4, pp. 471-482

2013

  1. Early cognitive stimulation compensates for memory and pathological changes in Tg2576 mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1832, Núm. 6, pp. 837-847

  2. Mineralocorticoid Receptor Activation Induces Insulin Resistance Through c-Jun N-terminal kinases in Response to Chronic Corticosterone: Cognitive Implications

    Journal of Neuroendocrinology, Vol. 25, Núm. 4, pp. 350-356

2012

  1. Cholinergic denervation exacerbates amyloid pathology and induces hippocampal atrophy in Tg2576 mice

    Neurobiology of Disease, Vol. 48, Núm. 3, pp. 439-446

2011

  1. Cardiotrophin-1 is a key regulator of glucose and lipid metabolism

    Cell Metabolism, Vol. 14, Núm. 2, pp. 242-253

2010

  1. Altered NCAM expression associated with the cholinergic system in alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 20, Núm. 2, pp. 659-668

  2. Insulin levels are decreased in the cerebrospinal fluid of women with prodomal alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 22, Núm. 2, pp. 405-413

2009

  1. Effects of chronic blockade of 5-HT6 receptors on NMDA receptor subunits expression

    Synapse, Vol. 63, Núm. 9, pp. 814-816

  2. Neonatal stress affects vulnerability of cholinergic neurons and cognition in the rat: Involvement of the HPA axis

    Psychoneuroendocrinology, Vol. 34, Núm. 10, pp. 1495-1505

2008

  1. Effects of 5-HT 6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat

    British Journal of Pharmacology, Vol. 155, Núm. 3, pp. 434-440